Hot Natural Products & Bioactive Compounds
BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.
Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.
Hot Products from BioCrick
Showing 2513 - 2520 of 9359 hot products
| Catalog No. | Product Name |
|---|---|
| BCC7071 | SKF 81297 hydrobromide |
|
Dopamine D1-like receptor agonist. Centrally active following systemic administration in vivo.
|
|
| BCC7072 | GYKI 52466 dihydrochloride |
|
Selective non-competitive AMPA receptor antagonist (IC<sub>50</sub> values are 10-20, ~ 450 and >> 50 <span class='symbol'>μ</span>M for AMPA- , kainate- and NMDA-induced responses respectively). Skeletal muscle relaxant and orally-active anticonvulsant. Has anti-proliferative effects in transformed cells. Also available as part of the AMPA Receptor. Also available as part of the Kainate Receptor.
|
|
| BCC7073 | SU 4312 |
|
Potent and selective inhibitor of VEGFR and PDGFR tyrosine kinases (IC<sub>50</sub> values are 0.8 and 19.4 <span class='symbol'>μ</span>M respectively). Selective over EGFR and c-Src tyrosine kinases.
|
|
| BCC7074 | PACOCF3 |
|
Phospholipase A2 inhibitor. Can also alter Ca2+ signaling in renal tubular cells.
|
|
| BCC7075 | AACOCF3 |
|
Inhibitor of cytosolic (85 kDa) phospholipase A2. Also inhibits fatty acid amide hydrolase (FAAH, anandamide amidase) in vitro.
|
|
| BCC7076 | Ghrelin (human) |
|
Endogenous agonist peptide for the ghrelin receptor (GHS-R1a). Produced mainly by the stomach, it stimulates release of growth hormone from the pituitary gland in vitro and in vivo, and regulates feeding, growth and energy production.
|
|
| BCC7077 | PPAHV |
|
Non-pungent vanilloid TRPV1 (VR1) receptor agonist (K<sub>i</sub> = 3.1 <span class='symbol'>μ</span>M) that displays non-cooperative binding. Induces apoptosis via a non-VR1 mechanism in Jurkat cells and causes vasoconstriction <em>in vivo</em>.
|
|
| BCC7078 | CGP 37849 |
|
Potent, selective and competitive NMDA receptor antagonist (Ki = 35 nM). Anticonvulsive following oral administration in vivo.
|
|